Scinnohub Pharmaceutical Co., Ltd.
Clinical trials sponsored by Scinnohub Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to cut bleeding in knee replacements Results expected Dec 2026 (estimated)
- New hope for thalassemia: drug trial targets anemia without transfusions Results expected Mar 2027 (estimated)
- New pill targets Hard-to-Treat cancers in early trial Results expected Jun 2027 (estimated)